Bexel Biotechnology Inc is categorized under Commercial Biotechnical Research in Fremont, CA and active since 2001.
Bexel Biotechnology Inc was established in 2001, and today employs 1 to 4, earning $50.000 to $99.999 per year. This is a Commercial Biotechnical Research business, which does work in the B2B market, and is classified as a Commercial Biotechnical Research, under code number 541711 by the NAICS.
If you are seeking more information, feel free to contact Vishawajit Nag at the company’s single location by writing to 46500 Fremont Boulevard # 706, Fremont, California CA 94538 or by phoning (510) 770-1175. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Bexel Biotechnology Inc |
Contact Person: | Vishawajit Nag |
Address: | 46500 Fremont Boulevard # 706, Fremont, California 94538 |
Phone Number: | (510) 770-1175 |
Annual Revenue (USD): | $50.000 to $99.999 |
Founded: | 2001 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2B (Business to Business) |
Business Category: | Commercial Biotechnical Research |
SIC Code: | 8731 |
NAICS Code: | 541711 |
Share This Business: |
Bexel Biotechnology Inc was started in 2001 to provide professional Commercial Biotechnical Research under the SIC code 8731 and NAICS code 541711. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $50.000 to $99.999 per annum.
Feel free to contact Vishawajit Nag for inquiries that concern Bexel Biotechnology Inc by calling the company number (510) 770-1175, as your correspondence is most welcome. Additionally, the physical location of the single location of Bexel Biotechnology Inc can be found at the coordinates 37.483001,-121.945467 as well as the street address 46500 Fremont Boulevard # 706 in Fremont, California 94538.
For its online presence, you may visit Bexel Biotechnology Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.